These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35243943)

  • 1. Understanding the mechanism underlying the anti-diabetic effect of dietary component: a focus on gut microbiota.
    Zhao Y; Li M; Wang Y; Geng R; Fang J; Liu Q; Kang SG; Zeng WC; Huang K; Tong T
    Crit Rev Food Sci Nutr; 2023; 63(25):7378-7398. PubMed ID: 35243943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of gut microbiota by bioactive compounds for prevention and management of type 2 diabetes.
    Sharma BR; Jaiswal S; Ravindra PV
    Biomed Pharmacother; 2022 Aug; 152():113148. PubMed ID: 35665671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Gut Microbiota in Type 2 Diabetes Mellitus and Its Complications: Novel Insights and Potential Intervention Strategies.
    Woldeamlak B; Yirdaw K; Biadgo B
    Korean J Gastroenterol; 2019 Dec; 74(6):314-320. PubMed ID: 31870137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.
    Ganesan K; Chung SK; Vanamala J; Xu B
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans.
    Liaqat I; Ali NM; Arshad N; Sajjad S; Rashid F; Hanif U; Ara C; Ulfat M; Andleeb S; Awan UF; Bibi A; Mubin M; Ali S; Tahir HM; Ul-Haq I
    Braz J Biol; 2021; 83():e242818. PubMed ID: 34378656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Metabolism and Interaction with Food Components.
    Vernocchi P; Del Chierico F; Putignani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy.
    Thakur PS; Aggarwal D; Takkar B; Shivaji S; Das T
    Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):21. PubMed ID: 35877085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in COVID-19: new insights from inside.
    Zhou B; Pang X; Wu J; Liu T; Wang B; Cao H
    Gut Microbes; 2023; 15(1):2201157. PubMed ID: 37078497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases.
    Sudheer S; Gangwar P; Usmani Z; Sharma M; Sharma VK; Sana SS; Almeida F; Dubey NK; Singh DP; Dilbaghi N; Khayat Kashani HR; Gupta VK; Singh BN; Khayatkashani M; Nabavi SM
    Biochimie; 2022 Feb; 193():38-63. PubMed ID: 34688789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Complications of Type-2 Diabetes.
    Iatcu CO; Steen A; Covasa M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and the Gut Microbiome.
    Lau WL; Tran T; Rhee CM; Kalantar-Zadeh K; Vaziri ND
    Semin Nephrol; 2021 Mar; 41(2):104-113. PubMed ID: 34140089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches.
    Varesi A; Campagnoli LIM; Chirumbolo S; Candiano B; Carrara A; Ricevuti G; Esposito C; Pascale A
    Pharmacol Res; 2023 Jun; 192():106799. PubMed ID: 37211239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
    Leclercq S; de Timary P; Stärkel P
    Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gut microbiota in the immunopathology of atherosclerosis: Focus on immune cells.
    Wang C; Deng H; Liu F; Yin Q; Xia L
    Scand J Immunol; 2022 Jul; 96(1):e13174. PubMed ID: 35474231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Insights into Immune-Microbiota Interactions and Preventive Role of Probiotics Against Autoimmune Diabetes Mellitus.
    Devi MB; Sarma HK; Mukherjee AK; Khan MR
    Probiotics Antimicrob Proteins; 2023 Aug; 15(4):983-1000. PubMed ID: 37171690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Gut Microbiota in High-Fat-Diet-Induced Diabetes: Lessons from Animal Models and Humans.
    Qi Y; Wang X
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.